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Ultrasonography works as an essential tool in diagnosing breast cancer.  For mass screen-
ing of breast cancer, mammography is used worldwide as a main tool.  However, in the 
screening of women with dense breasts and in detecting small cancer of the breast, ultra-
sonography is known to be more useful than mammography.   Most Japanese women con-
tract breast cancer in their 40s.  Women in their 40s have more dense breasts than those 
in their 50s.  It is expected that mass screening for breast cancer in the future will be done 
by a combined use of mammography and sonography.  A randomized control trial of the 
combined use is being carried out at present in Japan.  In recent years, the degree and dis-
tribution of tissue strain induced by tissue compression with an ultrasound device has en-
abled evaluation with color.  The method, real-time tissue elastography, is used as an aux-
iliary tool in diagnosing diseases of various organs.  Breast elastography images, classified 
into patterns and scores, have also begun to be widely used.  Compared with conventional 
B-mode sonography, elastography is superior in specificity.  Based on this fact, we have 
considered omitting available histological examinations for some breast lesions in the near 
future.  Furthermore, elastography was useful in preoperative assessment of the margin of 
breast cancer.  Further development of ultrasound elastography in the future is expected.
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Role of ultrasound imaging 
in breast screening
 
In mass screening for breast cancer, women are 
commonly examined by inspection and palpa-
tion of the breasts (Ota et al., 1989; Kanemura et 
al., 1999), mammography (Kerlikowsker et al., 
1995; Ohuchi et al., 1995; Jonsson et al., 2003) and 
sonography (Leconte et al., 2003; Yanagida et al., 
2003; Osako et al., 2007; Tohno et al., 2009).  In 
Japan, breast screening had been conducted since 
1987 by interview and inspection and palpation of 
the breasts, but the screening produced no signifi-
cant decrease in mortality (Ota et al., 1989; Kane-
mura et al., 1999).  Because the usefulness of mam-
mography had been established (Kerlikowsker et 
al., 1995; Ohuchi et al., 1995; Jonsson et al., 2003), 
breast screening with mammography was started 
in 2004.  Actually, the number of breast cancer 
patients detected at mammography screening has 
increased.  It is known, however, that mammogra-
phy has a problem when used for mass screening. 
In Japan, breast cancer is most common among 
women in their 40s who tend to have dense breasts 
(Wakai et al., 1995).  The problem with mammog-
raphy screening is that its sensitivity is often de-
creased in dense breast tissue (Osako et al., 2007; 
Tohno et al., 2009).  In a study on mammography 
screening, its sensitivity was observed to be lower 
in women in their 40s than in their 50s (Hasegawa 
et al., 2003).
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 On the other hand, ultrasonogra-
phy has some advantages such as ease 
of use and no emission of radiation, 
so it is widely used for individual ex-
aminations for breast cancer at many 
medical institutions.  In particular, ul-
trasound is superior in detecting small 
breast tumors 1 cm or less in diameter 
(Yanagida et al., 2003), and useful in 
mass screening of women with dense 
breasts (Leconte et al., 2003).  In 
2008, the 2nd edition of “Guideline 
for Breast Ultrasound:  Management 
and Diagnosis” was published by the 
Japan Association of Breast and Thy-
roid Sonography, which contributes to 
better understanding of the standard-
ized criteria for mass screening and 
requisites for minute examination. 
We examined a 74-year-old woman 
with mammography at breast screen-
Fig.1.  Mammograms obtained from a 74-year-old woman at mass screen-
ing.  A:  Massive image in the right breast, Area C.  B:  Mass image in the 
left breast, Area B.  
Fig. 2.  Ultrasound image of the left breast of the same woman in Fig. 1 
taken with conventional B-mode sonography.  A mass of about 5 mm in 
diameter is visible in Area C, which shows an interruption into the anterior 
border of the mammary gland.  This lesion was assessed as Category 4.  
ing.  Figure 1 shows a massive image in Area C of 
the right breast (Fig. 1A) and a mass image in Area 
B of the left breast (Fig. 1B).  Both were assessed 
as Category 3.  However, the ultrasound following 
mammography showed the massive in the right 
breast to be a cyst, and the mass in the left breast 
to be mastopathy.  Furthermore, as seen in Fig. 2, 
another very small mass, 5 mm in diameter, was 
newly discovered in the left breast area, where C 
bordered D.  The little mass had an interruption 
of the mammary gland.  According to the formu-
lated criteria for breast ultrasound screening (Japan 
Association of Breast and Thyroid 
Sonography, 2008), we assessed it as 
Category 4 and suspected malignancy. 
Examined with aspiration cytology, 
the patient showed positive for scir-
rhous carcinoma, and was treated 
with breast conserving surgery.  As 
described, ultrasound seems very use-
ful in detecting breast cancer, but its 
usefulness as a screening method has 
not clearly established.  No country 
adopts ultrasound for breast screening 
at present.  However, recently, per-
formance of screening in women at 
high risk for breast cancer was com-
pared between ultrasound with mam-
mography and mammography alone 
(Berg et al., 2008).  Adding this single 
technique to mammography yielded a 
higher detection rate of breast cancer.  
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 Because of these observations, a Japanese 
study group with Dr. Noriaki Ohuchi of Tohoku 
University as leader has started a randomized con-
trol trial to investigate the efficacy of ultrasound 
with mammography for breast cancer screening. 
We expect that results of the trial will prove the 
combination to be useful within a few years.
 
Real-time tissue elastography 
for breast disease
Recently, real-time tissue elastography was devel-
oped to evaluate tissue elasticity with ultrasound 
(Shiina et al., 2002), which has been gradually ap-
Fig. 3.  Clinical images 
obtained from our subjective 
cases are classified according 
to the Tsukuba Elastography 
Score.  Score 4 or over is 
determined to be malignant. 
plied clinically in diagnosing breast disease (Itoh et 
al., 2006).  This is a tissue elasticity imaging tech-
nic that visualizes the degree and distribution of 
strain induced by light compression in a real-time 
manner when artificial light compression is applied 
to breast tissue.  Results are noted when soft tissue 
receives greater strain, while stiff tissue receives 
less (Shiina et al., 2002).  Itoh and workers classi-
fied breast elastography images into 5 patterns (Fig. 
3) (Itoh et al., 2006), and reported the results using 
the Tsukuba Elastography Score (Itoh et al., 2006; 
Itoh, 2007).  Scores from 1 to 3 showing green im-
ages of strain with and without tense blue images 
are judged to be benign:  (1) strain in the entire 
hypoechoic area; (2) strain not seen in part of the 
Score 1
Score 2
Score 3
Score 4
Score 5
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Table 1.  Comparison of ultrasound imaging 
techniques for breast lesions
 Sensitivity Specificity Accuracy
 (%) (%) (%)
Sonography* 90  91.8 91.1
Elastogrpahy† 77.5 100 91.1
* Conventional B-mode sonography:  category 4 and over, 
diagnosed as malignant.
† Real-time tissue elastogrpahy:  score 4 and over, diag-
nosed as malignant. 
Fig. 4.  Ultrasound images obtained with 
conventional B-mode sonography and 
elastography.
A: Fibroadenoma of the right breast as-
sessed as Category 3 with conventional 
B-mode sonography (right) and Score 
1 with Tsukuba Elastography Score 
patterns (left).
B: Papillotubular carcinoma of the left 
breast assessed as Category 4 with 
conventional B-mode sonography 
(right) and Score 4 with Tsukuba Elas-
tography Score patterns (left). 
hypoechoic area; (3) strain only in the peripheral 
areas and not at the center of the hypoechoic area. 
Scores 4 and 5 showing blue images are diagnosed 
as malignant:  (4) no strain in the entire hypoechoic 
area; and (5) no strain either in the hypoechoic or 
surrounding areas.  Figure 4 shows ultrasound im-
ages of fibroadenoma (Fig. 4A) and papillotubular 
carcinoma (Fig. 4B) obtained by elastography and 
conventional B-mode sonography.  Elastography 
shows a green fibroadenoma mass in the region of 
interest (Fig. 4A left), which means that the mass is 
made of soft tissue.  We therefore judged the score 
of the lesion to be 1, based on Tsukuba Elastogra-
phy Score patterns.  On the other hand, the whole 
papillotubular carcinoma in the region of interest 
(Fig. 4B left) is blue, that is, the mass is more solid 
than the surrounding tissue.  We assessed this le-
sion as Score 4.  Differentiation from benign to 
malignant can be made even with conventional B-
mode sonography in many cases of breast disease. 
However, elastography has enabled examiners to 
judge in a more reliable manner, visually by color. 
Elastography seems very useful as a subsidiary di-
agnostic tool for all workers from little-experienced 
medical technologists to skilful breast-disease 
specialists or medical sonographers.  Table 1 shows 
the ratio of sensitivity, specificity and accuracy of 
conventional B-mode sonography and real-time 
tissue elastography performed in 101 patients with 
breast disease (61 benign and 40 malignant lesions) 
we have experienced.  Elastography showed lower 
A
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sensitivity than B-mode sonography, but 100% in 
specificity.  Furthermore, we confirmed no malig-
nant disease for lesions determined as Score 1.  It 
was highly expected that in the future, we can omit 
histological examinations such as aspiration cytol-
ogy or needle biopsy for lesions judged to be Score 
1 (Itoh et al., 2006; Itoh, 2007).  
 As described, we have great expectations in 
the future development of elastography.  But for 
breasts with big lesions of wide diameter, we must 
learn how to give proper pressure to the breast with 
an ultrasound device (Sato et al., 2008) which can 
be achieved through complete training.
 
 
Preoperative ultrasound 
to achieve negative margins
 
Breast conserving surgery for breast cancer has be-
come popular in these 10 and a few years.  One im-
portant point of note is to avoid the risk of leaving 
carcinomatous lesions.  For this, we must precisely 
grasp the degree of cancer invasion into the breast 
tissue and the presence and degree of the extensive 
intraductal component.  If the resected mass has 
a negative margin, the disease-free survival ratio 
also improves (Fortin et al., 1999).  As a tool for 
preoperative assessment of the extent of cancer 
in the breast, 3-dimensional MR mammography 
which utilizes MRI is superior to mammography 
or ultrasound in providing more accurate anatomic 
information (Esserman et al., 1999; Nakamura et 
al., 2002). On the other hand, to achieve negative 
margins in the operating room, the usefulness of 
ultrasound with its easy portability and improve-
ments in technology is well known (Henry-Tillman 
et al., 2001).  However, ultrasound is superior in 
specificity but inferior to MRI in sensitivity (Tamaki 
et al., 2002).  Considering the above facts, we ap-
plied ultrasound elastography to the assessment of 
the extent of breast cancer before surgery.  As seen 
in Fig. 5, elastography clearly visualized some blue 
infiltration (Fig. 5A, white arrow) which was not 
clear with conventional B-mode sonography.  His-
topathological examination of the resected mass 
confirmed the blue depicted to be an infiltration 
Fig. 5.  Ultrasound images and pathology of a breast mass.
A: Ultrasound images of breast cancer with conventional 
B-mode sonography (right) and elastography (left). 
Elastography clearly visualizes a blue infiltration (white 
arrow) which is not clear with conventional B-mode 
sonography. 
B: Hitstopathological apperance of the resected mass.  The 
infiltration to the surrounding tissue (black arrow) is 
clear (hematoxylin and eosin stain).  Bar = 3.75 mm. 
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to the surrounding tissue (Fig. 5B, black arrow). 
As described above, we think that elastography is 
fully applicable not only to differential diagnosis 
between benign and malignant tumors, but also to 
preoperative assessment of infiltrating margins.
 In conclusion, ultrasound is an essential tool 
in diagnosing breast cancer, and its significance at 
mass screening seems to increase.  Elastography is 
a newly developed ultrasound-based function, and 
a very useful auxiliary tool in diagnosing breast 
cancer.  Further development of ultrasound elastog-
raphy in the future is highly expected. 
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